Pittsburgh, PANCT07330778Now EnrollingIRB Ready

Mild to Moderate Asthma Clinical Trial in Pittsburgh, PA

Access cutting-edge mild to moderate asthma treatment through this clinical trial at a research site in Pittsburgh. Study-provided care at no cost to qualified participants.

Sponsored by Celldex Therapeutics

Quick Self-Assessment

See if you qualify for this Pittsburgh location

Preparing your pre-screening questions…

Expert Care in Pittsburgh

Access mild to moderate asthma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related mild to moderate asthma treatment provided free

Apply for This Pittsburgh Location

Check if you qualify for this mild to moderate asthma clinical trial in Pittsburgh, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Pittsburgh

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Pittsburgh site if eligible
  4. 4Begin participation

About This Mild to Moderate Asthma Study in Pittsburgh

This is a study to determine the safety, pharmacodynamics (PD), and pharmacokinetics (PK) of CDX-622 in adults with mild to moderate asthma.

Sponsor: Celldex Therapeutics

Who Can Participate

Inclusion Criteria

Males and females, ≥ 18 years of age
Diagnosis of mild to moderate asthma for at least 12 months
Pre-bronchodilator forced expiratory volume in 1 second (FEV1) ≥ 70% of predicted normal
Airway reversibility ≥ 12% and 200 mL improvement in FEV1
Both males and females of child-bearing potential must agree to use contraception during the study and for 150 days after treatment
Willing and able to comply with all study requirements and procedures Key

Exclusion Criteria

Females who are pregnant or nursing
Pulmonary disease other than asthma
Systemic diseases with elevated eosinophils other than asthma
Hospitalization for treatment of asthma in the past 12 months or required oral corticosteroids due to asthma within the past 6 months
History of needing ventilator support due to asthma
Current nasal polyps
Severe or uncontrolled asthma
History of smoking or vaping within the past 6 months
Tuberculosis, hepatitis B or C virus, or HIV
Immunomodulating biologic therapies within the past 3 months for non-extended half-life biologics.
Prior receipt of TSLP or KIT inhibitors such as tezepelumab or briquilimab Additional protocol defined inclusion and exclusion criteria could apply.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Pittsburgh?

Yes, this clinical trial (NCT07330778) has an active research site in Pittsburgh, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Mild to Moderate Asthma Treatment Options in Pittsburgh, PA

If you're searching for mild to moderate asthma treatment options in Pittsburgh, PA, this clinical trial (NCT07330778) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Pittsburgh research site is actively enrolling participants for this clinical trial. You'll receive care from experienced mild to moderate asthma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all mild to moderate asthma clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Pittsburgh, PA

See all heart attack clinical trials recruiting in Pittsburgh — not just this study.

Browse Heart Attack Trials in Pittsburgh →

Browse More Trials by Condition

Heart Attack TrialsRheumatoid Arthritis TrialsAnkylosing Spondylitis TrialsAsthma TrialsMyocardial Infarction TrialsInterstitial Lung Disease TrialsAll Conditions →

Ready to Join in Pittsburgh?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Pittsburgh, PA